Clinical Trial Update: Study of SOM0226 in Familial Amyloid Polyneuropathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of SOM0226 in familial amyloid polyneuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Amyloid Polyneuropathy

Drugs mentioned

• SOM0226

Snippet

Sponsor: SOM Innovation Biotech SA | Conditions: Familial Amyloid Polyneuropathy (FAP) | Phase 1, Phase 2 | Status: COMPLETED